These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6976)

  • 41. Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia.
    Sawynok J; Reid A
    Brain Res; 1987 Sep; 419(1-2):156-65. PubMed ID: 3119144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain.
    Hutchins DA; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):19-29. PubMed ID: 4269287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of the periaqueductal grey matter and spinal 5-hydroxytryptaminergic pathways in morphine analgesia: effcts of lesions and 5-hydroxytryptamine depletion.
    Deakin JF; Dostrovsky JO
    Br J Pharmacol; 1978 May; 63(1):159-65. PubMed ID: 206302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tolerance to morphine-induced calcium depletion in regional brain areas: characterization with reserpine and protein synthesis inhibitors.
    Ross DH
    Br J Pharmacol; 1975 Nov; 55(3):431-7. PubMed ID: 1203629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
    Corrodi H; Fuxe K
    Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
    [No Abstract]   [Full Text] [Related]  

  • 46. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.
    Reches A; Burke RE; Kuhn CM; Hassan MN; Jackson VR; Fahn S
    J Pharmacol Exp Ther; 1983 Jun; 225(3):515-21. PubMed ID: 6864517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants.
    Pettibone DJ; Totaro JA; Pflueger AB
    Eur J Pharmacol; 1984 Jul; 102(3-4):425-30. PubMed ID: 6489435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain.
    Roffler-Tarlov S
    Biochem Pharmacol; 1975 Jul; 24(13-14):1321-5. PubMed ID: 1148020
    [No Abstract]   [Full Text] [Related]  

  • 49. Peripheral catecholamines and memory: characteristics of syrosingopine-induced amnesia.
    Walsh TJ; Palfai T
    Pharmacol Biochem Behav; 1979 Oct; 11(4):449-52. PubMed ID: 42929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cannabis-induced potentiation of morphine analgesia in rat--role of brain monoamines.
    Ghosh P; Bhattacharya SK
    Indian J Med Res; 1979 Aug; 70():275-80. PubMed ID: 574857
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of 6-hydroxydopamine on the antinociceptive action of morphine.
    Slater P; Blundell C
    Eur J Pharmacol; 1978 Apr; 48(3):237-47. PubMed ID: 639852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Octopamine, dopamine and noradrenaline content of the brain of the locust, Schistocerca gregaria.
    Robertson HA
    Experientia; 1976 May; 32(5):552-4. PubMed ID: 776646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diverse effect of hydrochlorothiazide in relation to the hypotensive activity of reserpine, rescinnamine, syrosingopine, 1, 4-dihydrazino-phthlazine (alone or associated with reserpine), hexamethonium and guanethidine].
    MIELE E; MARMO E; PREZIOSI P
    Arch Ital Sci Farmacol; 1961 Oct; 11():367-70. PubMed ID: 14473573
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparison of the dose-response effects of morphine on brain amines, analgesia and activity in mice.
    Fennessy MR; Lee JR
    Br J Pharmacol; 1972 Jun; 45(2):240-8. PubMed ID: 5048647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alterations in morphine analgesia produced by chronic deficits of brain catecholamines or serotonin: role of analgesimetric procedure.
    York JL; Maynert EW
    Psychopharmacology (Berl); 1978 Mar; 56(2):119-25. PubMed ID: 417362
    [No Abstract]   [Full Text] [Related]  

  • 56. [Significance of catecholamines for analgesic effect of morphine].
    Vedernikov IuP; Afrikanov II
    Farmakol Toksikol; 1970; 33(2):154-9. PubMed ID: 5425620
    [No Abstract]   [Full Text] [Related]  

  • 57. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
    Rech RH; Carr LA; Moore KE
    J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
    [No Abstract]   [Full Text] [Related]  

  • 58. Reduced analgesic effects of morphine after bilateral lesions of the locus coeruleus in rats.
    Kostowski W; Jerlicz M; Bidziński A; Hauptmann M
    Pol J Pharmacol Pharm; 1978; 30(1):49-53. PubMed ID: 643740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serotonin depletion induced by reserpine is attenuated by prophylactic administration of lithium.
    Reches A; Liu KP; Karpiak SE; Fahn S; Cooper TB; Suckow R; Jackson V; Tamir H
    Eur J Pharmacol; 1985 Jul; 113(2):225-31. PubMed ID: 2412842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Niaprazine, a selective brain catecholamine depletor.
    Keane PE; Benedetti MS
    Neuropharmacology; 1979 Jul; 18(7):595-600. PubMed ID: 158713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.